missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Phospho-BRCA2 (Ser3291) Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA537499
Description
A suggested positive control for Western blot is 293 cells.
Breast Cancer Type 2 susceptibility protein (BRCA2) is a tumor-suppressor protein reported to be involved in double-strand break repair, homologous recombination and S-phase checkpoint activation.Chemical Identifiers
| Phospho-BRCA2 (Ser3291) | |
| -20°C | |
| Polyclonal | |
| Liquid | |
| IgG | |
| Human, Mouse, Rat | |
| BRCA2 | |
| brca 2; BRCA1/BRCA2-containing complex, subunit 2; BRCA2; brca-2; BRCA2 DNA repair associated; BRCA2, DNA repair associated; BRCC2; breast and ovarian cancer susceptibility gene, early onset; breast and ovarian cancer susceptibility protein 2; breast cancer 2; breast cancer 2 tumor suppressor; breast cancer 2, early onset; breast cancer 2, mutation 1, University of Wisconsin-Madison; breast cancer susceptibility protein 2; breast cancer type 2 susceptibility protein; Breast cancer type 2 susceptibility protein homolog; BROVCA2; FACD; FAD; FAD1; FANCB; FANCD; FANCD1; Fanconi anemia group D1 protein; Fanconi anemia group D1 protein homolog; GLM3; mutant BRCA2; PNCA2; RAB163; RP11-298P3.4; XRCC11 | |
| BRCA2 | |
| Primary | |
| Antigen affinity chromatography |
| 1 mg/mL | |
| Western Blot | |
| Unconjugated | |
| Rabbit | |
| RUO | |
| PBS with 50% glycerol and 0.02% sodium azide; pH 7.4 | |
| O35923, P51587, P97929 | |
| 12190, 360254, 675 | |
| Peptide sequence around phosphorylation site of Serine 3291 (F-V-S(p)-P-A) derived from Human BRCA2. | |
| Antibody |
Specifications
| Phospho-BRCA2 (Ser3291) | |
| Polyclonal | |
| Unconjugated | |
| BRCA2 | |
| brca 2; BRCA1/BRCA2-containing complex, subunit 2; BRCA2; brca-2; BRCA2 DNA repair associated; BRCA2, DNA repair associated; BRCC2; breast and ovarian cancer susceptibility gene, early onset; breast and ovarian cancer susceptibility protein 2; breast cancer 2; breast cancer 2 tumor suppressor; breast cancer 2, early onset; breast cancer 2, mutation 1, University of Wisconsin-Madison; breast cancer susceptibility protein 2; breast cancer type 2 susceptibility protein; Breast cancer type 2 susceptibility protein homolog; BROVCA2; FACD; FAD; FAD1; FANCB; FANCD; FANCD1; Fanconi anemia group D1 protein; Fanconi anemia group D1 protein homolog; GLM3; mutant BRCA2; PNCA2; RAB163; RP11-298P3.4; XRCC11 | |
| Rabbit | |
| Antigen affinity chromatography | |
| RUO | |
| 12190, 360254, 675 | |
| -20°C | |
| Liquid |
| Western Blot | |
| 1 mg/mL | |
| PBS with 50% glycerol and 0.02% sodium azide; pH 7.4 | |
| O35923, P51587, P97929 | |
| BRCA2 | |
| Peptide sequence around phosphorylation site of Serine 3291 (F-V-S(p)-P-A) derived from Human BRCA2. | |
| 100 μL | |
| Primary | |
| Human, Mouse, Rat | |
| Antibody | |
| IgG |